66 related articles for article (PubMed ID: 20872562)
1. Serum KL-6 levels in lung cancer patients with or without interstitial lung disease.
Miyazaki K; Kurishima K; Kagohashi K; Kawaguchi M; Ishikawa H; Satoh H; Hizawa N
J Clin Lab Anal; 2010; 24(5):295-9. PubMed ID: 20872562
[TBL] [Abstract][Full Text] [Related]
2. Circulating markers of interstitial lung disease and subsequent risk of lung cancer.
Shiels MS; Chaturvedi AK; Katki HA; Gochuico BR; Caporaso NE; Engels EA
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2262-72. PubMed ID: 21828236
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort.
Millan-Billi P; Castellví I; Martinez-Martinez L; Mariscal A; Barril S; D'Alessandro M; Franquet T; Castillo D
Arch Bronconeumol; 2024 Jun; 60(6):350-355. PubMed ID: 38644152
[TBL] [Abstract][Full Text] [Related]
4. Digital Clubbing Is Associated with Higher Serum KL-6 Levels and Lower Pulmonary Function in Patients with Interstitial Lung Disease.
Shiraishi K; Jinta T; Nishimura N; Nakaoka H; Tsugitomi R; Okafuji K; Kitamura A; Tomishima Y; Deshpande GA; Tamura T
Can Respir J; 2018; 2018():3640967. PubMed ID: 29610629
[TBL] [Abstract][Full Text] [Related]
5. Challenges in the Management of Lung Cancer in ILD.
Tzouvelekis A; Tsiri P; Sampsonas F
Arch Bronconeumol; 2024 May; ():. PubMed ID: 38821775
[No Abstract] [Full Text] [Related]
6. [The diagnostic value of serum KL-6 in connective tissue disease associated interstitial lung disease].
Wu X; Wu LJ; Luo CN; Shi YM; Zou JM; Meng XY
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3172-3175. PubMed ID: 31694110
[No Abstract] [Full Text] [Related]
7. Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis.
Hu C; Wu C; Yang E; Huang H; Xu D; Hou Y; Zhao J; Li M; Xu Z; Zeng X; Wang Q
Clin Rheumatol; 2019 Aug; 38(8):2181-2187. PubMed ID: 30888566
[TBL] [Abstract][Full Text] [Related]
8. Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease.
Lee JS; Lee EY; Ha YJ; Kang EH; Lee YJ; Song YW
Arthritis Res Ther; 2019 Feb; 21(1):58. PubMed ID: 30764869
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of KL-6 in idiopathic interstitial pneumonia.
Zheng P; Liu X; Huang H; Guo Z; Wu G; Hu H; Cai C; Luo W; Wei N; Han Q; Sun B
J Thorac Dis; 2018 Aug; 10(8):4724-4732. PubMed ID: 30233844
[TBL] [Abstract][Full Text] [Related]
10. Sequential changes of serum KL-6 predict the progression of interstitial lung disease.
Jiang Y; Luo Q; Han Q; Huang J; Ou Y; Chen M; Wen Y; Mosha SS; Deng K; Chen R
J Thorac Dis; 2018 Aug; 10(8):4705-4714. PubMed ID: 30233842
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and outcome of lung cancer in patients with fibrosing interstitial lung disease.
Han SJ; Kim HH; Hyun DG; Ji W; Choi CM; Lee JC; Kim HC
BMC Pulm Med; 2024 Mar; 24(1):136. PubMed ID: 38491506
[TBL] [Abstract][Full Text] [Related]
12. Identifying the link between serum VEGF and KL-6 concentrations: a correlation analysis for idiopathic pulmonary fibrosis interstitial lung disease progression.
Zhong B; Luo S
Front Med (Lausanne); 2023; 10():1282757. PubMed ID: 38105892
[TBL] [Abstract][Full Text] [Related]
13. Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer.
Park HK; Yoon CS; Na YO; Lee JK; Oh HJ; Park HY; Kho BG; Kim TO; Shin HJ; Kwon YS; Oh IJ; Kim YI; Lim SC; Kim YC; Park CK
Sci Rep; 2023 Oct; 13(1):18126. PubMed ID: 37872370
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and prognostic impact of acute exacerbations in patients with interstitial lung disease and lung cancer: A single-center, retrospective cohort study.
Hyun DG; Han SJ; Ji W; Choi CM; Lee JC; Kim HC
Thorac Cancer; 2023 Nov; 14(33):3323-3330. PubMed ID: 37772425
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of lysophosphatidylcholine 14:0 as a biomarker for drug-induced lung disease.
Saito K; Gemma A; Tatsumi K; Hattori N; Ushiki A; Tsushima K; Saito Y; Abe M; Horimasu Y; Kashiwada T; Mori K; Sato M; Nishiya T; Takamatsu K; Sun Y; Arakawa N; Izumi T; Ohno Y; Saito Y; Hanaoka M
Sci Rep; 2022 Nov; 12(1):19819. PubMed ID: 36396675
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of SUV
Akaike K; Saruwatari K; Matsushima R; Fujino K; Morinaga J; Oda S; Takahashi H; Shiraishi S; Okabayashi H; Hamada S; Tomita Y; Masunaga A; Saeki S; Ikeda K; Ichiyasu H; Suzuki M; Sakagami T
J Thorac Dis; 2022 Oct; 14(10):3801-3810. PubMed ID: 36389305
[TBL] [Abstract][Full Text] [Related]
17. Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II.
d'Alessandro M; Bergantini L; Cavallaro D; Gangi S; Cameli P; Conticini E; Siena Covid Unit ; Frediani B; Dotta F; Bargagli E
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206372
[TBL] [Abstract][Full Text] [Related]
18. Serum Krebs von den Lungen-6 for Predicting the Severity of COVID-19 Lung Injury: A Systematic Review and Meta-Analysis.
Pramana Witarto A; Samarta Witarto B; Er Putra AJ; Pramudito SL; Rosyid AN
Iran Biomed J; 2021 Nov; 25(6):381-9. PubMed ID: 34641641
[TBL] [Abstract][Full Text] [Related]
19. The role of mucin 1 in respiratory diseases.
Ballester B; Milara J; Cortijo J
Eur Respir Rev; 2021 Mar; 30(159):. PubMed ID: 33536260
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic predictive values of circulating KL-6 for interstitial lung disease: A PRISMA-compliant systematic review and meta-analysis.
Zhang H; Chen L; Wu L; Huang J; Li H; Wang X; Weng H
Medicine (Baltimore); 2020 Apr; 99(16):e19493. PubMed ID: 32311922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
